发明名称 |
ORALLY ADMINISTRABLE TABLET FOR INTESTINAL LAVAGE |
摘要 |
<p>Disclosed is an orally administrable tablet for intestinal lavage, which is small in size and can be administered easily. The orally administrable tablet for intestinal lavage does not leave a residue in the intestinal tract after the intestinal lavage, and has dissolvability equivalent to that of conventional sodium phosphate-containing tablets in which crystalline cellulose is blended. Specifically disclosed is an orally administrable tablet for intestinal lavage, which contains the following components (A) and (B), while having a water-insoluble content of not more than 5% by mass. (A) 80-95% by mass of sodium phosphate (B) (B1) 7-11% by mass of hydroxypropylcellulose, not less than 99% of which passes through a mesh with openings of 350 µm, and a 2% by mass aqueous solution of which has a viscosity of 2.0-10.0 mPa·s; (B2) 5-13% by mass of hydroxypropylcellulose, not less than 99% of which passes through a mesh with openings of 150 µm, and a 2% by mass aqueous solution of which has a viscosity of 3.0-5.9 mPa·s; or (B3) 7-11% by mass of hydroxypropylcellulose, not less than 99% of which passes through a mesh with openings of 150 µm, and a 2% by mass aqueous solution of which has a viscosity of 6.0-4000 mPa·s</p> |
申请公布号 |
WO2011024467(A1) |
申请公布日期 |
2011.03.03 |
申请号 |
WO2010JP05285 |
申请日期 |
2010.08.27 |
申请人 |
ZERIA PHARMACEUTICAL CO., LTD.;NOMURA, MASAFUMI;NISHIYAMA, TETSUYUKI;ICHIKAWA, MARI;FUKAYA, KYOKO |
发明人 |
NOMURA, MASAFUMI;NISHIYAMA, TETSUYUKI;ICHIKAWA, MARI;FUKAYA, KYOKO |
分类号 |
A61K33/42;A61K9/20;A61K31/717;A61K49/00;A61P1/10 |
主分类号 |
A61K33/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|